Results 31 to 40 of about 98,939 (114)
Breast Cancer (BC) has evolved from traditional morphological analysis to molecular profiling, identifying new subtypes. Ki-67, a prognostic biomarker, helps classify subtypes and guide chemotherapy decisions.
Mehwish Mooghal +5 more
doaj +1 more source
Background The significance of human epidermal growth factor receptor 2 (Her2) and nucleus-associated antigen Ki-67 expression remains controversial in gastric adenocarcinoma (GaC).
Zhijian Wei +3 more
doaj +1 more source
Argyrophilic proteins associated with nucleolar organizer regions (Ag-NOR proteins) and Ki-67 antigen were investigated in patients with lung adenocarcinoma.
D. S. Kobyakov +4 more
doaj
Expression of Progestrone Receptor and Proliferative Marker ki 67, in Various Grades of Meningioma [PDF]
Meningiomas are slow-growing neoplasms which recur locally, their morphologic grading is simple but do not always correlate with patient outcome. The aim of present study is to evaluate the status of progesterone receptor (PR) and proliferation marker ...
Nasrin Shayanfar +2 more
doaj +2 more sources
Background: Breast cancer is the most common diagnosed female cancer. Breast cancer is also the leading cause of cancer death in females accounting for 13.7% of female cancer-related mortality globally.
Hosein Kamranzadeh +6 more
doaj +1 more source
Ki-67 staining pattern as a prognostic biomarker for advanced acral melanoma [PDF]
Background Acral cutaneous melanoma (ACM) is an aggressive skin cancer, especially when diagnosed in the advanced stage. The Ki-67 is a rapid tool for proliferation rate analysis.
Marcel Arakaki Asato +7 more
doaj +2 more sources
Immunohistochemical evaluation of p53 and Ki-67 proteins in colorectal adenomas
CONTEXT: The appearance of adenomas and their progression to adenocarcinomas is the result of an accumulation of genetic changes in cells of the intestinal mucosa inherited or acquired during life.
Walysson Alves Tocantins de Sousa +3 more
doaj +1 more source
In Response to "Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision Making: A New Way of Counting". [PDF]
Belderbos RA +2 more
europepmc +1 more source
Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision-Making: A New Way of Counting. [PDF]
Bulloni M, Pattini L, Pelosi G.
europepmc +1 more source
In Ukraine 60,9% of patients with gastric cancer die within 1 year after ascertainment of diagnosis. Aim: In order to investigate the effect of Ki-67 overexpression on life expectancy, study was conducted among 129 patients with gastric cancer of 0 ...
O. M. Levyk +3 more
doaj +1 more source

